A recent study has found at Clostridioides difficile (C. diff) comes with costs, as well as increased hospital stays, when the infection is acquired in the hospital, according to an article on the MD website.
In the study, investigators examined adult patients both with hospital-acquired C. Diff and without between April 1, 2012 and March 31, 2016.
The team estimated the cost of C. diff to be about $5.4 billion in the US, $4.7 billion of which was incurred in healthcare settings, mostly due to hospitalizations and recurrence.
The average healthcare cost for patients with the C. diff infection was $43,718 compared to $19,513 for those patients without.
Alleged Ransomware Administrator Extradited from South Korea
Design Plans Unveiled for New Intermountain St. Vincent Regional Hospital
Ground Broken on New Pediatric Health Campus in Dallas
Pre-Construction Strategies for Successful Facilities Projects
Geisinger Finds Success with Violence Prevention Efforts